The Lancet Psychiatry
The Lancet Psychiatry is a monthly peer-reviewed psychiatry and mental health journal published by Elsevier as part of the Lancet family and launched in June 2014, covering clinical research, reviews and comment across mental health, with a 2025 Journal Impact Factor of 21.1《柳叶刀·精神病学》是由(Elsevier)出版、属于《柳叶刀》系列并于 2014 年 6 月创刊的精神病学与精神健康同行评审月刊,涵盖精神健康领域的临床研究、综述与评论,2025 年影响因子为 21.1。
Scope
- It is an authoritative forum for key opinion leaders in medicine, government and health systems to influence clinical practice and global policy该刊是医学、政府与卫生系统关键意见领袖影响临床实践与全球政策的权威平台。
- It publishes clinical research, expert reviews and comment and opinion in mental health该刊刊载精神健康领域的临床研究、专家综述以及评论与观点。
- Its topics include psychopharmacology, psychotherapy and psychosocial approaches to all psychiatric disorders across the life course其选题包括精神药理学、心理治疗,以及针对全生命周期各类精神障碍的心理社会干预。
- It covers innovative treatments and the biological research underpinning them, novel methods of service delivery and new ways of thinking about mental illness该刊报道创新疗法及其背后的生物学研究、新型服务提供方式,以及对精神疾病的新思考。
- It advocates strongly for the rights of people with mental health disorders and highlights the voices of service users该刊大力倡导精神健康障碍患者的权利,并突出服务使用者的声音。
- It aims to give a clear, independent perspective on practice-changing research shaping clinical psychiatry该刊致力于对塑造临床精神病学的实践变革性研究给出清晰、独立的视角。
History
- It was launched in print and online in June 2014, following earlier Lancet specialty journals such as The Lancet Oncology and The Lancet Neurology该刊于 2014 年 6 月以纸质与网络形式创刊,延续了更早的《柳叶刀》专科刊(如《柳叶刀·肿瘤学》与《柳叶刀·神经病学》)的传统。
- It was founded and edited from 2014 to 2021 by Niall Boyce该刊由 Niall Boyce 于 2014 年创办,并由他主编至 2021 年。
- Joan Marsh joined the Lancet group in November 2013 as Deputy Editor to help launch the journal, and became Editor-in-Chief in November 20212013 年 11 月 Joan Marsh 以副编辑身份加入《柳叶刀》团队协助创办该刊,并于 2021 年 11 月出任主编。
- It publishes landmark Commissions, such as the 2018 Lancet Psychiatry Commission on psychological treatments research in tomorrow's science该刊发表具有里程碑意义的委员会报告,如 2018 年《柳叶刀·精神病学》心理治疗研究委员会报告。[1]
- Its Journal Impact Factor was 77.056 in 2022, 24.8 in 2024 and 21.1 in 2025其影响因子为 2022 年的 77.056、2024 年的 24.8 与 2025 年的 21.1。
- It is indexed in PubMed, MEDLINE, Web of Science with both SCIE and SSCI, and Scopus该刊被(PubMed)、(MEDLINE)、(Web of Science)的(SCIE)与(SSCI)以及(Scopus)收录。
Editors
- Its Editor-in-Chief is Joan Marsh, who read Natural Sciences at Cambridge University and holds a PhD in molecular biology其主编为 Joan Marsh,她在(Cambridge University)攻读自然科学并拥有分子生物学博士学位。
- Its founding Editor-in-Chief was Niall Boyce, a psychiatrist trained at Oxford University who joined The Lancet as a senior editor in 2010其创刊主编为 Niall Boyce,他是在(Oxford University)受训的精神科医师,2010 年以资深编辑身份加入《柳叶刀》。
- After leaving the journal in 2021, Niall Boyce became Head of Field Building for Mental Health at Wellcome2021 年离任后,Niall Boyce 转至(Wellcome)担任精神健康领域建设负责人。
- Sophia Davis is a senior editor of the journalSophia Davis 是该刊的资深编辑。
- Its editors host the journal's podcast In Conversation With, talking with authors about their research该刊编辑主持其播客(In Conversation With),与作者探讨其研究。
References
- ^The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science. The Lancet Psychiatry, 2018, 5(3):237-286. doi:10.1016/S2215-0366(17)30513-8